Suppr超能文献

后循环动脉瘤患者采用 Pipeline 栓塞装置治疗的发病率和死亡率:Pipeline 栓塞装置国际回顾性研究的亚组分析。

Morbidity and Mortality in Patients With Posterior Circulation Aneurysms Treated With the Pipeline Embolization Device: A Subgroup Analysis of the International Retrospective Study of the Pipeline Embolization Device.

机构信息

Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois.

Department of Neurosurgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.

出版信息

Neurosurgery. 2018 Sep 1;83(3):488-500. doi: 10.1093/neuros/nyx467.

Abstract

BACKGROUND

The safety of PipelineTM Embolization Device (PED; Medtronic Inc, Dublin, Ireland) in posterior circulation aneurysms is still controversial.

OBJECTIVE

To study complications associated with the treatment of posterior circulation aneurysms by conducting a subgroup analysis from the International Retrospective Study of PED registry.

METHODS

Data from 91 consecutive patients with 95 posterior circulation aneurysms at 17 centers between July 2008 to February 2013 were analyzed. The primary endpoint was defined as any complication leading to neurological morbidity or death. The outcome predictors were calculated using Kaplan-Meier and Cox regression methods.

RESULTS

The mean aneurysm size was 13.8 mm. Aneurysm types were saccular (36.8%), fusiform (29.5%), dissecting (28.4%), and others (5.3%). The median follow-up was 21.1 mo. Twelve (13.2%) patients encountered a primary endpoint event. In multivariate analysis for the primary endpoint, use of ≥3 PEDs and fusiform shape compared with other shapes had hazard ratios (HRs) of 7.77 (95% confidence interval [CI], 2.48-25.86; P = .0007) and 3.48 (95% CI, 1.06-13.39; P = .0488), respectively. The multivariate HR of aneurysm size for neurological morbidity after PED implantation was 1.11 (95% CI, 1.04-1.18; P = .0015), and HRs of ruptured aneurysm and age for neurological mortality were 8.1 (95% CI, 1.31-41.26; P = .0197) and 1.07 (95% CI, 1.02-1.15; P = .0262), respectively. Basilar artery aneurysm had an HR of 3.54 (95% CI, 1.12-14.18, P = .0529) in the univariate analysis for major outcomes.

CONCLUSION

PED implantation may be considered for the treatment of posterior circulation aneurysms, especially of saccular or dissecting type. Our major complications appear to be comparable to those reported previously after clipping and coiling in the literature. Neurointerventionists should consider the shape, size, rupture, and location of complex posterior circulation aneurysms as well as age and PED number before the PED placement.

摘要

背景

PipelineTM 栓塞装置(PED;美敦力公司,都柏林,爱尔兰)在后循环动脉瘤中的安全性仍存在争议。

目的

通过对 Pipeline 栓塞装置国际回顾性研究注册中心的亚组分析,研究与治疗后循环动脉瘤相关的并发症。

方法

对 2008 年 7 月至 2013 年 2 月期间 17 个中心的 91 例连续患者的 95 例后循环动脉瘤进行数据分析。主要终点定义为任何导致神经功能障碍或死亡的并发症。使用 Kaplan-Meier 和 Cox 回归方法计算预后预测因子。

结果

平均动脉瘤大小为 13.8mm。动脉瘤类型为囊状(36.8%)、梭形(29.5%)、夹层(28.4%)和其他类型(5.3%)。中位随访时间为 21.1 个月。12 例(13.2%)患者发生主要终点事件。多变量分析主要终点时,与使用其他形状的 PED 相比,使用≥3 个 PED 和梭形形状的患者的危险比(HR)分别为 7.77(95%置信区间[CI],2.48-25.86;P=0.0007)和 3.48(95%CI,1.06-13.39;P=0.0488)。PED 植入后动脉瘤大小与神经功能障碍的多变量 HR 为 1.11(95%CI,1.04-1.18;P=0.0015),破裂动脉瘤和年龄与神经死亡率的 HR 分别为 8.1(95%CI,1.31-41.26;P=0.0197)和 1.07(95%CI,1.02-1.15;P=0.0262)。在单变量分析中,基底动脉动脉瘤的主要结果的 HR 为 3.54(95%CI,1.12-14.18,P=0.0529)。

结论

PED 植入术可考虑用于治疗后循环动脉瘤,尤其是囊状或夹层型。我们的主要并发症似乎与文献中夹闭和线圈治疗后报道的并发症相当。神经介入医生在放置 PED 之前,应考虑复杂后循环动脉瘤的形状、大小、破裂和位置,以及年龄和 PED 数量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验